Cencora Inc. (COR)vsCosmos Health Inc. (COSM)
COR
Cencora Inc.
$325.08
-0.67%
HEALTHCARE · Cap: $63.59B
COSM
Cosmos Health Inc.
$0.34
+1.49%
HEALTHCARE · Cap: $16.65M
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 544743% more annual revenue ($325.78B vs $59.79M). COR leads profitability with a 0.5% profit margin vs -31.0%. COR earns a higher WallStSmart Score of 62/100 (C+).
COR
Buy62
out of 100
Grade: C+
COSM
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-43.9%
Fair Value
$254.20
Current Price
$325.08
$70.88 premium
Intrinsic value data unavailable for COSM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 134 in profit
Large-cap with strong market position
Growing faster than its price suggests
Reasonable price relative to book value
Revenue surging 37.9% year-over-year
Areas to Watch
Premium valuation, high expectations priced in
0.5% margin — thin
Operating margin of 1.2%
Trading at 33.1x book value
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -63.8% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : COR
The strongest argument for COR centers on Return on Equity, Market Cap, PEG Ratio. PEG of 0.78 suggests the stock is reasonably priced for its growth.
Bull Case : COSM
The strongest argument for COSM centers on Price/Book, Revenue Growth. Revenue growth of 37.9% demonstrates continued momentum.
Bear Case : COR
The primary concerns for COR are P/E Ratio, Profit Margin, Operating Margin. Thin 0.5% margins leave little buffer for downturns.
Bear Case : COSM
The primary concerns for COSM are EPS Growth, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
COR profiles as a value stock while COSM is a hypergrowth play — different risk/reward profiles.
COSM carries more volatility with a beta of 4.47 — expect wider price swings.
COSM is growing revenue faster at 37.9% — sustainability is the question.
COSM generates stronger free cash flow (-4M), providing more financial flexibility.
Bottom Line
COR scores higher overall (62/100 vs 41/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
Cosmos Health Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Cosmos Holdings Inc. is a vertically integrated pharmaceutical company. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?